Health care investors in Shanghai, China
Updated 16 Nov 2026
Venture funds
7 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Qiming Venture Partners Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio. Shanghai, China |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 50% | 12 |
| 2 | Med-Fine Capital Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma. Shanghai, China |
Health care, Biotech | Early stage venture | 30% | 5 |
| 3 | Shanghai Biomedical Industrial Equity Investment Fund Shanghai Biomedical Industrial Equity Investment Fund focuses on biomedical industry development areas, with recent backings including Haimai Medical and Healsun Biopharm. Huangpu, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 57% | 4 |
| 4 | BioTrack Capital BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 33% | 3 |
| 5 | Boyuan Capital Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Late stage venture | 38% | 2 |
| 6 | Lilly Asia Ventures Lilly Asia Ventures invests in promising life science companies, including Precede Biosciences and Akura Medical. Shanghai, China |
Health care, Biotech | Early stage venture, Late stage venture | 29% | 2 |
| 7 | 5Y Capital 5Y Capital makes early-stage venture investments, with recent investments in Etern and CellCentric. Xuhui, China |
Artificial intelligence, Commerce | Seed, Early stage venture, Late stage venture | 31% | 2 |
Table 1. Health care investors in Shanghai, China: venture capital and micro VC funds ranked by health care companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Qiming Venture Partners | Venture capital firm | Shanghai, China | •••@qimingvc.com | (+86) ••• |
| Lilly Asia Ventures | Venture capital firm | Shanghai, China | •••@lillyasiaventures.com | +86 21••• |
| New Alliance Capital | Private equity firm | Shanghai, China | •••@nac-capital.com | 86-21-••• |
| Med-Fine Capital | Venture capital firm | Shanghai, China | •••@medfinecapital.com | +86 21••• |
| Pan-Lin Capital | Venture capital firm | Shanghai, China | •••@panlincap.com | 021-51••• |
| Luminous Ventures (former Lightspeed China Partners) | Venture capital firm | Shanghai, China | •••@luminousvc.com | +86 21••• |
| Fosun International | Venture capital firm | Shanghai, China | •••@fosun.com | (86 21••• |
| GP Capital | Private equity firm | Shanghai, China | •••@gpcapital.com.cn | +86212••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 45 of the 63 health care investors in Shanghai, China have a published email address, 45 a phone number and 59 a website.
- Qiming Venture Partners has the most recorded investments, 1,106, 555 of them as lead investor.
- 39 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Qiming Venture Partners is an investor in 21 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Moffett AI's $150.0M Series C on 3 November 2026.
- Software is the most common sector across their 794 portfolio companies (61%).
- Early stage venture is the most common investment stage, recorded for 55 of them (87%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Health care investors in Shanghai, China
30 of 63, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Houmo.AI, Infinigence, AusperBio | 21 | 1,106 | 555 | 104 | •••@qimingvc.com | (+86) ••• | In the CSV |
| 2 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | Health care, Biotech | Precede Biosciences, Akura Medical | 2 | 237 | 68 | 49 | •••@lillyasiaventures.com | +86 21••• | In the CSV |
| 3 | Shanghai Biomedical Industrial Equity Investment Fund | Venture capital firm | Huangpu, China | Health care, Biotech | Haimai Medical, AccuPulse, Surgerii Technology | 4 | 60 | 34 | 6 | |||
| 4 | BioTrack Capital | Venture capital firm | Shanghai, China | Health care, Biotech | Yuce Biotechnology, Shenluo Medical, Rigen Biotech | 3 | 85 | 28 | 5 | +86-02••• | ||
| 5 | New Alliance Capital | Private equity firm, Venture capital firm | Shanghai, China | Health care, Biotech | Degron Therapeutics | 1 | 96 | 9 | 10 | •••@nac-capital.com | 86-21-••• | In the CSV |
| 6 | 5Y Capital | Venture capital firm | Xuhui, China | Artificial intelligence, Commerce | Etern, CellCentric, BOTINKIT | 4 | 345 | 108 | 28 | +86 20••• | In the CSV | |
| 7 | Med-Fine Capital | Venture capital firm | Shanghai, China | Health care, Biotech | Leadinno Medical Valley, Artivila Therapeutics, Degron Therapeutics | 5 | 77 | 23 | 3 | •••@medfinecapital.com | +86 21••• | In the CSV |
| 8 | Pan-Lin Capital | Venture capital firm | Shanghai, China | Health care, Biotech | Kunteng Tech, AOSSCI, Levinthal | 3 | 74 | 31 | 6 | •••@panlincap.com | 021-51••• | In the CSV |
| 9 | Prox Ventures | Venture capital firm | Shanghai, China | Biotech, Health care | Leadinno Medical Valley | 1 | 71 | 14 | 1 | In the CSV | ||
| 10 | Luminous Ventures (former Lightspeed China Partners) | Venture capital firm | Shanghai, China | Hardware, Commerce | Enjosim, Yin Gong Technology, Urtopia | 8 | 182 | 70 | 13 | •••@luminousvc.com | +86 21••• | |
| 11 | Fosun International | Venture capital firm | Shanghai, China | Artificial intelligence, Fintech | ROBOT++ | 1 | 122 | 53 | 24 | •••@fosun.com | (86 21••• | In the CSV |
| 12 | GP Capital | Private equity firm | Shanghai, China | Hardware, Artificial intelligence | Moffett AI | 1 | 102 | 37 | 11 | •••@gpcapital.com.cn | +86212••• | In the CSV |
| 13 | Hengxu Capital | Private equity firm | Jiading, China | Health care, Biotech | Kai Medtech, Runxin Micro Technology, Xingsai Bio | 3 | 82 | 27 | 6 | •••@hengxucapital.com | 021-22••• | |
| 14 | Dalton Venture | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Astribot | 1 | 67 | 25 | 1 | •••@daltonventure.cn | 021-62••• | |
| 15 | Boyuan Capital | Venture capital firm | Shanghai, China | Health care, Biotech | Yuce Biotechnology, Rigen Biotech | 2 | 42 | 16 | 5 | In the CSV | ||
| 16 | Long Hill Capital | Venture capital firm | Shanghai, China | Health care, Hardware | Aibo Medical Robot | 1 | 42 | 15 | 1 | •••@lhcap.cn | In the CSV | |
| 17 | Sunland Fund | Venture capital firm | Shanghai, China | Health care, Biotech | Qianglian Zhichuang, Jiyuan Medical, Better Medtech | 35 | 16 | 1 | •••@sunlandfund.com | 86-21-••• | ||
| 18 | WisdoMont Asset Management | Investment bank, Private equity firm | Shanghai, China | Health care, Hardware | Weihansi Shengwu, X-Imaging, Hanhong Technology | 22 | 4 | 1 | •••@wisdomont.com | 021-58••• | In the CSV | |
| 19 | SBCVC | Private equity firm, Venture capital firm | Shanghai, China | Hardware, Fintech | Global Technology, Guoke Tanmei | 2 | 146 | 47 | 18 | •••@sbcvc.com | (86)21••• | In the CSV |
| 20 | Chengwei Capital | Venture capital firm | Shanghai, China | Hardware, Biotech | Huizhi International Tourism, Full-Life Technologies | 2 | 113 | 43 | 11 | •••@chengwei.com | In the CSV | |
| 21 | Marathon Venture Partners | Venture capital firm | Shanghai, China | Fintech, Health care | Natus, Yuanyi Biotech, Doctor AI Yisheng Intelligence | 60 | 29 | 0 | •••@marathonvp.com | +86108••• | In the CSV | |
| 22 | Yonghua Capital | Micro VC fund, Private equity firm | Shanghai, China | Artificial intelligence, Hardware | Shexu Technology, Yimu Technology, Mino Space | 3 | 180 | 56 | 15 | •••@yonghuacapital.com.cn | +02150••• | In the CSV |
| 23 | Loyal Valley Capital | Private equity firm | Shanghai, China | Health care, Education | Surgerii Technology | 1 | 103 | 48 | 27 | •••@loyalvalleycapital.com | +86 (2••• | In the CSV |
| 24 | Volcanics Venture | Micro VC fund, Venture capital firm | Changning, China | Artificial intelligence, Hardware | Thinktech | 1 | 101 | 29 | 3 | +86 21••• | In the CSV | |
| 25 | Ameba Capital | Venture capital firm | Shanghai, China | Hardware, Education | ExponTech, Huamei Haolian | 2 | 85 | 29 | 10 | •••@amebacapital.com | In the CSV | |
| 26 | Linear Capital | Venture capital firm | Shanghai, China | Artificial intelligence, Hardware | SynMetaBio, Dishi Medical, ReaVis | 3 | 83 | 26 | 1 | +61 36••• | In the CSV | |
| 27 | Cenova | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Agile Medical, Umai Technology, Orient Speech Therapy Center | 59 | 29 | 6 | •••@cenova.com | 86-21-••• | In the CSV | |
| 28 | Grand Flight Investment | Private equity firm, Venture capital firm | Shanghai, China | Biotech, Health care | YolTech Therapeutics | 1 | 52 | 19 | 8 | •••@gfinvestment.com | 021-20••• | |
| 29 | Yijing Capital | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Artivila Therapeutics | 1 | 45 | 14 | 3 | •••@yijingcapital.com | 021-68••• | |
| 30 | Neovision Capital | Venture capital firm | Shanghai, China | Biotech, Health care | Matrixtime Robotics, Xingsai Bio | 2 | 36 | 9 | 5 | •••@neovisioncap.com | +8621 ••• |
Table 2. Health care investors in Shanghai, China: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 63.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Shanghai, China | 21 | 154 | Houmo.AI, Infinigence, AusperBio |
| 2 | Luminous Ventures (former Lightspeed China Partners) | Shanghai, China | 8 | 48 | Enjosim, Yin Gong Technology, Urtopia |
| 3 | Med-Fine Capital | Shanghai, China | 5 | 8 | Leadinno Medical Valley, Artivila Therapeutics, Degron Therapeutics |
| 4 | 5Y Capital | Xuhui, China | 4 | 57 | Etern, CellCentric, BOTINKIT |
| 5 | Shanghai Biomedical Industrial Equity Investment Fund | Huangpu, China | 4 | 11 | Haimai Medical, AccuPulse, Surgerii Technology |
| 6 | Pan-Lin Capital | Shanghai, China | 3 | 14 | Kunteng Tech, AOSSCI, Levinthal |
| 7 | Yonghua Capital | Shanghai, China | 3 | 43 | Shexu Technology, Yimu Technology, Mino Space |
| 8 | BioTrack Capital | Shanghai, China | 3 | 9 | Yuce Biotechnology, Shenluo Medical, Rigen Biotech |
| 9 | Hengxu Capital | Jiading, China | 3 | 11 | Kai Medtech, Runxin Micro Technology, Xingsai Bio |
| 10 | Linear Capital | Shanghai, China | 3 | 20 | SynMetaBio, Dishi Medical, ReaVis |
| 11 | Neovision Capital | Shanghai, China | 2 | 6 | Matrixtime Robotics, Xingsai Bio |
| 12 | SBCVC | Shanghai, China | 2 | 27 | Global Technology, Guoke Tanmei |
| 13 | Ameba Capital | Shanghai, China | 2 | 22 | ExponTech, Huamei Haolian |
| 14 | Jianmu Investment | Minhang, China | 2 | 4 | Lianyi Microelectronics, Huakong Zhijia |
| 15 | Boyuan Capital | Shanghai, China | 2 | 6 | Yuce Biotechnology, Rigen Biotech |
Table 3. Health care investors in Shanghai, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Moffett AI | Moffett AI designs AI chips and provides terminal and cloud AI chip acceleration solutions. | Artificial intelligence | Los Altos, United States | Series C | $150.0M | 2026-11-03 | $322.8M | GP Capital | 11 to 50 | 2018 |
| Global Technology | Global Technology supplies automotive intelligent driving systems. | Hardware | Mumbai, India | Series C | $90.0M | 2026-11-03 | $153.9M | SBCVC | 101 to 250 | 2001 |
| Enjosim | Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. | Biotech | Shanghai, China | Series B | $30.1M | 2026-11-02 | $30.1M | Luminous Ventures (former Lightspeed China Partners) | 51 to 100 | 2021 |
| Guoke Tanmei | Guoke Tanmei develops materials for carbon-based energy storage. | Energy | Huzhou, China | Seed | $13.9M | 2026-11-02 | $13.9M | SBCVC | 51 to 100 | 2022 |
| ExponTech | ExponTech provides data infrastructure solutions built on distributed architecture. | Hardware | Luoyang, China | Series A | $15.0M | 2026-10-20 | $43.6M | Ameba Capital | 101 to 250 | 2020 |
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen, China | Series A | $14.1M | 2026-10-15 | $33.0M | Long Hill Capital | 2020 | |
| Astribot | Astribot develops intelligent robotic systems that assist people in everyday and professional settings. | Artificial intelligence | Shenzhen, China | Series B | $149.4M | 2026-10-13 | $297.2M | Dalton Venture | 101 to 250 | 2022 |
| Infinigence | Infinigence develops AI infrastructure and computing solutions for training and deploying AI models. | Artificial intelligence | Xuhui, China | Series C | $343.7M | 2026-10-12 | $587.5M | Qiming Venture Partners | 51 to 100 | 2023 |
| Shexu Technology | Shexu Technology develops automatic industrial design software products powered by AI computing. | Artificial intelligence | Shanghai, China | Series B | $14.9M | 2026-09-17 | $47.6M | Yonghua Capital | 51 to 100 | 2020 |
| Yuce Biotechnology | Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. | Biotech | Suzhou, China | Series B | $7.4M | 2026-08-31 | $22.4M | BioTrack Capital, Boyuan Capital | 101 to 250 | 2019 |
Table 4. Health care investors in Shanghai, China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 488 | 61% |
| Health care | 217 | 27% |
| Hardware | 164 | 21% |
| Artificial intelligence | 144 | 18% |
| Biotech | 114 | 14% |
| Fintech | 80 | 10% |
| Commerce | 64 | 8% |
| Education | 48 | 6% |
| Energy | 23 | 3% |
| Cybersecurity | 12 | 2% |
Table 5. Health care investors in Shanghai, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 55 | 87% |
| Late stage investors | 40 | 63% |
| Seed investors | 37 | 59% |
| Venture investors | 24 | 38% |
| Private equity investors | 17 | 27% |
| Post IPO investors | 10 | 16% |
Table 6. Health care investors in Shanghai, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| Shanghai | 53 | 84% |
| Xuhui | 3 | 5% |
| Changning | 2 | 3% |
| Jingan | 2 | 3% |
| Huangpu | 1 | 2% |
| Jiading | 1 | 2% |
| Minhang | 1 | 2% |
Table 7. Health care investors in Shanghai, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 4 | 7% |
| 2010s | 38 | 64% |
| 2000s | 12 | 20% |
| 1990s | 5 | 8% |
Table 8. Health care investors in Shanghai, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded health care companies and its headquarters is in Shanghai, China. On 16 November 2026 that is 63 investors.
- 45 rows carry an email address and 45 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 63 rows: 4 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care investors in Shanghai, China are on the list?
- 63, in the file dated 16 November 2026. 39 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 45 of the 63 carry an email address in the download and 45 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 63 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 63 rows, 45 firm email addresses and 45 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 30 of the 45 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.